According to Google’s latest report, more than 2 million researchers in 190 couries are now using AlphaFold to help accelerate the fight against malaria and pave the way for treatmes. New Parkinson’s use.
AlphaFold is an artificial ielligence-based bioinformatics tool developed by DeepMind, a subsidiary of Google, and the European Bioinformatics Institute EMBL-EBI. This tool is able to predict the three-dimensional structure of proteins with high accuracy. This ability helps biologists to have a better and more accurate understanding of the function of proteins in the human body and other living organisms. Determining the structure of proteins using sequence has been one of the big challenges in biology, and AlphaFold has been able to overcome this big challenge.
That being said, AI has enabled our progress in a wide range of scieific fields, from hydrology to neuroscience to climate.
But for AI to deliver the next generation of scieific breakthroughs, scieists need funding, computing power, ierdisciplinary expertise, and access to infrastructure, including esseial datasets, such as the protein data bank that powers AlphaFold.
For this reason, Google has set aside a budget of 20 million dollars to support academic and non-profit organizations around the world; Organizations that use artificial ielligence to address more complex problems.
Google said in its announceme that “we will use all our capacity to ideify and announce the names of related organizations.”
It should be noted that these figures are separate from the 200 million dollars that Google has provided to organizations that have used artificial ielligence to accelerate their scieific work in the last 5 years.
“Time and time again, funding, technology and collaboration have come together to drive scieific discovery,” Google coinued in the announceme. We hope that this new funding will help grow more Nobel-level achievemes that will improve the lives of millions of people, and that other philahropic, public and private investors will join us in investing in meaningful, long-term outcomes.”
